scholarly article | Q13442814 |
P50 | author | Serge Barcy | Q95993335 |
Soren Gantt | Q42647995 | ||
P2093 | author name string | Timothy M Rose | |
Qing Zhang | |||
Ryan Basom | |||
Yuko Ogata | |||
Corey Casper | |||
Michael R Dyen | |||
Minako Ikoma | |||
P2860 | cites work | Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells | Q24555724 |
Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines | Q24594085 | ||
The microRNA Registry | Q24600787 | ||
Secretory mechanisms and intercellular transfer of microRNAs in living cells | Q24603413 | ||
Upregulated miR-106a plays an oncogenic role in pancreatic cancer | Q53071807 | ||
MicroRNA-150 functions as a tumor suppressor in osteosarcoma by targeting IGF2BP1. | Q53280332 | ||
Kaposi's Sarcoma | Q54197804 | ||
Heterogeneity of the Ro/SSA antigen and autoanti-Ro/SSA response: evidence of the four antigenically distinct forms | Q68872895 | ||
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma | Q72633360 | ||
Association of a pool of HIV-1 with erythrocytes in vivo: a cohort study | Q74424811 | ||
EBV-encoded miRNAs | Q84271499 | ||
The Kaposi sarcoma–associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element | Q40758382 | ||
HIV and complement: role of the complement system in HIV infection. | Q40807008 | ||
MicroRNA-26a inhibits TGF-β-induced extracellular matrix protein expression in podocytes by targeting CTGF and is downregulated in diabetic nephropathy | Q40848218 | ||
An information-intensive approach to the molecular pharmacology of cancer. | Q41134023 | ||
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. | Q41839438 | ||
High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. | Q42365746 | ||
Circulating red cell-derived microparticles in human malaria | Q42712727 | ||
5'-YRNA fragments derived by processing of transcripts from specific YRNA genes and pseudogenes are abundant in human serum and plasma | Q43789607 | ||
Complement changes in falciparum malaria infection | Q44226083 | ||
Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates | Q45117910 | ||
Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage | Q45739908 | ||
MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway | Q46255425 | ||
Tumor-derived exosomes modulate PD-L1 expression in monocytes. | Q46329110 | ||
Cancer in Africa: epidemiology and prevention | Q46412074 | ||
The distinct proteome of placental malaria parasites | Q47837556 | ||
von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation | Q48028775 | ||
Complement Activation in Severe Plasmodium falciparum Malaria | Q48037526 | ||
Differential TGFβ pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. | Q36712914 | ||
MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1. | Q36870550 | ||
OncomiRs: the discovery and progress of microRNAs in cancers | Q36951319 | ||
Role of transforming growth factor-beta superfamily signaling pathways in human disease | Q37099520 | ||
Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma | Q37237479 | ||
Kaposi's sarcoma-associated herpesvirus encodes a mimic of cellular miR-23 | Q37252707 | ||
MicroRNA function in cancer: oncogene or a tumor suppressor? | Q37655612 | ||
BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma | Q37659154 | ||
Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. | Q37669854 | ||
Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells | Q37727998 | ||
Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. | Q37888397 | ||
MicroRNAs as mediators of viral evasion of the immune system | Q38082296 | ||
The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein | Q38335734 | ||
Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study | Q38399107 | ||
Herpesviruses shape tumour microenvironment through exosomal transfer of viral microRNAs | Q38610039 | ||
MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma | Q38739661 | ||
RNY (YRNA)-derived small RNAs regulate cell death and inflammation in monocytes/macrophages | Q39038743 | ||
An update: Epstein-Barr virus and immune evasion via microRNA regulation. | Q39409293 | ||
Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis | Q39454179 | ||
Complement mediates the binding of HIV to erythrocytes | Q40517628 | ||
Human herpesvirus 8 seroconversion in Kenyan women by enzyme-linked immunosorbent assay and immunofluorescence assay | Q40559469 | ||
Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression. | Q40635375 | ||
Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria | Q40666888 | ||
Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression | Q40686716 | ||
miR-221 Is Required for Endothelial Tip Cell Behaviors during Vascular Development | Q24630712 | ||
Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
A viral microRNA functions as an orthologue of cellular miR-155 | Q24652947 | ||
Functional requirement of noncoding Y RNAs for human chromosomal DNA replication | Q24670318 | ||
Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155 | Q24681400 | ||
KSHV-Mediated Angiogenesis in Tumor Progression | Q26742030 | ||
"Asymptomatic" Malaria: A Chronic and Debilitating Infection That Should Be Treated | Q26771205 | ||
Measurement of protein using bicinchoninic acid | Q26778491 | ||
Functional roles of non-coding Y RNAs | Q26866273 | ||
Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles | Q27973498 | ||
Exosomes as miRNA Carriers: Formation-Function-Future | Q28075728 | ||
Identification of virus-encoded microRNAs | Q28259309 | ||
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice | Q28262487 | ||
RNAi, microRNAs, and human disease | Q28273238 | ||
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 | Q29547403 | ||
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins | Q29615034 | ||
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Q29616316 | ||
Fast and Accurate Protein False Discovery Rates on Large-Scale Proteomics Data Sets with Percolator 3.0. | Q31125225 | ||
A subset of hY RNAs is associated with erythrocyte Ro ribonucleoproteins | Q33258130 | ||
Impact of HIV infection and Kaposi sarcoma on human herpesvirus-8 mucosal replication and dissemination in Uganda | Q33401242 | ||
Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. | Q33432690 | ||
Targeting the transforming growth factor-beta signaling pathway in human cancer | Q33517772 | ||
Plasma levels of apolipoprotein A1 in malaria-exposed primigravidae are associated with severe anemia | Q33526296 | ||
Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy | Q33610926 | ||
KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine | Q33761091 | ||
Plasma Viral miRNAs Indicate a High Prevalence of Occult Viral Infections | Q33817618 | ||
Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus | Q33883910 | ||
Mucosal shedding of human herpesvirus 8 in men. | Q33924644 | ||
Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma | Q33974199 | ||
New inflammation-related biomarkers during malaria infection | Q34058614 | ||
Kaposi's sarcoma herpesvirus microRNAs target caspase 3 and regulate apoptosis | Q34102689 | ||
Exploitation of the complement system by oncogenic Kaposi's sarcoma-associated herpesvirus for cell survival and persistent infection | Q34257818 | ||
Kaposi's Sarcoma-Associated Herpesvirus microRNAs | Q34273195 | ||
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells | Q34307544 | ||
Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway. | Q34347568 | ||
Augmented plasma microparticles during acute Plasmodium vivax infection | Q34388168 | ||
Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas | Q34395302 | ||
Regulation of herpesvirus lifecycle by viral microRNAs | Q34412460 | ||
MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus | Q34453771 | ||
HIV infection and human herpesvirus-8 oral shedding among men who have sex with men. | Q34547024 | ||
A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses | Q34547697 | ||
miR-150 functions as a tumour suppressor in human colorectal cancer by targeting c-Myb | Q34571580 | ||
Role of host microRNAs in Kaposi's sarcoma-associated herpesvirus pathogenesis | Q34580878 | ||
Kaposi's sarcoma-associated herpesvirus downregulates transforming growth factor β2 to promote enhanced stability of capillary-like tube formation | Q34594849 | ||
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen | Q34735858 | ||
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma | Q34784133 | ||
Systemically circulating viral and tumor-derived microRNAs in KSHV-associated malignancies. | Q34845533 | ||
The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo | Q34973323 | ||
Nelfinavir impairs glycosylation of herpes simplex virus 1 envelope proteins and blocks virus maturation | Q35077455 | ||
Identification of circulating biomarkers in sera of Plasmodium knowlesi-infected malaria patients--comparison against Plasmodium vivax infection | Q35108515 | ||
EVpedia: a community web portal for extracellular vesicles research | Q35221358 | ||
Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda | Q35328464 | ||
A brief review on biomarkers and proteomic approach for malaria research | Q35632089 | ||
Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis | Q35670992 | ||
Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. | Q35689725 | ||
Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. | Q35784707 | ||
Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling. | Q35834474 | ||
A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway | Q35983671 | ||
Profile of Exosomal and Intracellular microRNA in Gamma-Herpesvirus-Infected Lymphoma Cell Lines | Q36128494 | ||
RNY-derived small RNAs as a signature of coronary artery disease | Q36142332 | ||
Impact of antiretroviral therapy on the incidence of Kaposi's sarcoma in resource-rich and resource-limited settings | Q36162341 | ||
Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. | Q36247828 | ||
MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virions | Q36397498 | ||
Kaposi's sarcoma and its associated herpesvirus | Q36487309 | ||
Factors determining the occurrence of submicroscopic malaria infections and their relevance for control | Q36503207 | ||
Patterns of human herpesvirus-8 oral shedding among diverse cohorts of human herpesvirus-8 seropositive persons | Q36565716 | ||
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor | Q36591375 | ||
Principles and effects of microRNA-mediated post-transcriptional gene regulation. | Q36617803 | ||
Cells release subpopulations of exosomes with distinct molecular and biological properties | Q36638253 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | DESeq2 | Q113018293 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | malaria | Q12156 |
microRNA expression | Q60681249 | ||
P304 | page(s) | e0192659 | |
P577 | publication date | 2018-02-09 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite | |
P478 | volume | 13 |
Search more.